| Literature DB >> 35966388 |
Zi-Rong Bi1,2, Meng-Lu Hu2, Yong-Zhong Jiang3, Er-Hu Xiong2, Bo-Wen Shu4, Si-Qi Li5, Han-Wei Chen1,6, Xiao-Hua Chen1,7, Xiao-Ming Zhou2.
Abstract
Gold nanoparticles (AuNPs) colorimetric assays based on distance-dependent optical characteristics have been widely employed for bioanalysis. However, this assay is not effective for visually detecting low-concentration targets due to the faint color change. Here, we developed a handheld nano-centrifugal device which could separate the crosslinked and non-crosslinked AuNPs. Results showed that the handheld nano-centrifugal device could easily reach more than 6000 r/min within 10 s simply by stretching and tightening the coiled rope in an appropriate rhythm. Further, combined with the CRISPR/Cas12a nucleic acids recognition system, a field-deployable colorimetric platform termed handheld nano-centrifugal device assisted CRISPR/Cas12a (Hand-CRISPR) has been validated. Moreover, clinical diagnostics applications for Epstein-Barr virus (EBV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detection with high sensitivity and accuracy (100% consistency with reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) test results) have been demonstrated. Overall, the Hand-CRISPR platform showed great promise in point-of-care-test (POCT) application, expected to become a powerful supplement to the standard nucleic acid testing method in remote or poverty-stricken areas. Supplementary Information: The online version contains supplementary material available at 10.1007/s41664-022-00232-0. © The Nonferrous Metals Society of China 2022.Entities:
Keywords: CRISPR/Cas12a; Centrifugal device; Clinical diagnostics; Gold nanoparticles; Nucleic acids assay
Year: 2022 PMID: 35966388 PMCID: PMC9361950 DOI: 10.1007/s41664-022-00232-0
Source DB: PubMed Journal: J Anal Test ISSN: 2509-4696
Scheme 1The design of centrifugation-based colorimetric assay
Fig. 1Validation of the handheld nano-centrifugal device. a Materials used to construct the handheld nano-centrifugal device. b Images of manual centrifugal operation. c Separation result of crosslinked AuNPs by benchtop centrifuge at different rotational speeds. d Schematic diagram of a physical model of the handheld nano-centrifugal device. e Separation performance of the handheld nano-centrifugal device with a different radius on crosslinked AuNPs within 60 s. (In the experiments shown in c and e, the size of AuNPs is 13 nm. Data are represented as mean ± standard error of the difference between means of three technical replicates)
Fig. 2Construction of a high-efficient AuNP colorimetric system by handheld nano-centrifugal device. a The crosslinking behavior of two different-sized AuNPs under different concentrations of ssDNA linker. b Screening of the shortest centrifugal time required for a handheld nano-centrifugal device to separate two different-sized AuNPs crosslinked aggregates. c Evaluation of the crosslinking behavior of two different-sized AuNPs before and after centrifugation with the increasing number of poly (A) for affinity labeling. d Schematic diagram of two different-sized AuNPs crosslinking behavior when increasing the number of poly (A) for affinity labeling. (Data are represented as mean ± standard error of the difference between means of three technical replicates)
Fig. 3Detection of Epstein-Barr virus by the Hand-CRISPR platform. a Schematic diagram of EBNA-1 gene sequence in EB virus recognized by Cas12a/crRNA system followed by colorimetric analysis. b Colorimetric analysis of RPA products using a tenfold serial dilution of EBV genomic samples. (n = 3 technical replicates, two-tailed Student’s test; ns, not significant; **p < 0.01; ***p < 0.001; and ****p < 0.0001; error bars represent three different individual experiments. NTC represents no-template control). c A linear relationship between the UV–vis absorbance (A530) and the concentration of EBV genomic DNA. Data are represented as mean ± standard error of the difference between means of three technical replicates. d Schematic workflow of the Hand-CRISPR platform applied to rapid detection of EB virus. e The naked-eye detection of EBV positive samples by the Hand-CRISPR platform. f Heat map analysis based on the UV–vis spectrum results. Assessment of clinical sample detection (n = 23). The “+” and “−” represent positive and negative samples, respectively, as confirmed by qPCR
Fig. 4Detection of SARS-CoV-2 by the Hand-CRISPR platform. a Schematic diagram of the full-length SARS-CoV-2 genome and the amplified region of Orf1ab gene (from 14,019 to 14,200) and N gene (from 29,099 to 29,275). b and c Sensitivity analyses of the Orf1ab gene and N gene, respectively. d Specificity analysis of the Hand-CRISPR platform for SARS-CoV-2 and other viruses. (n = 3 technical replicates, two-tailed Student’s test; ns, not significant; **, p < 0.01; ***, p < 0.001; and ****, p < 0.0001; error bars represent three different individual experiments. NTC represents no-template control). e Schematic workflow of the Hand-CRISPR platform applied to rapid detection of SARS-CoV-2. f Assessment of clinical sample detection (n = 20). The heat map represents the values of the UV–vis spectra results. The “+” and “−” represent positive and negative samples, respectively, as confirmed by RT-qPCR